Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of metform...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gharakhani, Mohsen, Neghab, Nosrat, Farimani, Marzie
Médium: Artigo
Jazyk:Inglês
Vydáno: Royan Institute 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://ncbi.nlm.nih.gov/pubmed/24963365
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky